Stay updated with breaking news from Mindset Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canadian next-generation psychedelics developer Mindset Pharma (OTCMKTS: MSSTF) has entered into a definitive agreement by which Otsuka America Inc., the U.S. arm of Otsuka Pharmaceutical Co., would acquire all its outstanding shares in an all-cash transaction for approximately $60 (CA$80) million.
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JUNE 30, 2023 AND 2022 ... -Today at 07:43 am- MarketScreener
One investor predicts many companies will go bankrupt, and while some will merge with other distressed companies or form joint ventures.
As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also filed a patent application over a proprietary polymorph,
As Reunion Neuroscience REUN and Mindset Pharma MSSTF continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran…